Drugs & Targets Infinimmune, Grid Therapeutics form partnership for deep sequencing of B cells for NSCLC drug discovery January 05, 2024Vol.50 No.01
FDA, Friends identify next steps for dose optimization, pragmatic trials, academic-led studies for drug approvals December 15, 2023Vol.49 No.46By Matthew Bin Han Ong
Guest Editorial “Do no harm” must guide social media for healthcare professionals December 15, 2023Vol.49 No.46By Samir N. Khleif, Raphael E. Pollock and Robert A. Winn
In Brief UChicago Medicine receives $20M gift to support cancer care and research pavilion December 15, 2023Vol.49 No.46
